1 Eight healthy volunteers and eight patients suffering from chronic obstructive pulmonary disease (COPD) received 30 mg prednisolone as plain (P) and enteric-coated tablets (EP) in a randomised, cross-over manner. Plasma prednisolone and cortisol and blood glucose were measured over 24 h.
|Number of pages||5|
|Journal||British Journal of Clinical Pharmacology|
|Publication status||Published - 1992|
Adair, C. G., Mccallion, O., McElnay, J., Scott, M. G., Hamilton, B. A., Mccann, J. P., Stanford, C. F., & Nicholls, D. P. (1992). A PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF PLAIN AND ENTERIC-COATED PREDNISOLONE TABLETS. British Journal of Clinical Pharmacology, 33, 495-499.